Showing results (41-50 of 71) with videos related to
Sort By:
Pageof 8
Vaccine|October 12, 2007
Tail scarification with Vaccinia virus Lister as a model for evaluation of smallpox vaccine potency in miceSharon Melamed, Melamed Sharon, Nir Paran, et al.Microbiology Spectrum|September 22, 2023
Generation of recombinant mAbs to vaccinia virus displaying high affinity and potent neutralizationTal Noy-Porat, Hadas Tamir, Ron Alcalay, et al.Scientific Reports|November 6, 2020
Influenza virus infection augments susceptibility to respiratory Yersinia pestis exposure and impacts the efficacy of antiplague antibiotic treatmentsYaron Vagima, David Gur, Noam Erez, et al.Nature|May 12, 2021
SARS-CoV-2 uses a multipronged strategy to impede host protein synthesisYaara Finkel, Avi Gluck, Aharon Nachshon, et al.Iscience|October 3, 2022
Anti-SARS-CoV-2 immunoadhesin remains effective against Omicron and other emerging variants of concernHadas Cohen-Dvashi, Jonathan Weinstein, Michael Katz, et al.Emerging Infectious Diseases|March 9, 2019
Diagnosis of Imported Monkeypox, Israel, 2018Noam Erez, Hagit Achdout, Elad Milrot, et al.Vaccines|May 25, 2024
Induction of Superior Systemic and Mucosal Protective Immunity to SARS-CoV-2 by Nasal Administration of a VSV-ΔG-Spike VaccineYfat Yahalom-Ronen, Sharon Melamed, Boaz Politi, et al.Nature Communications|April 16, 2024
Synergistic effect of two human-like monoclonal antibodies confers protection against orthopoxvirus infectionHadas Tamir, Tal Noy-Porat, Sharon Melamed, et al.Nature|September 9, 2020
The coding capacity of SARS-CoV-2Yaara Finkel, Orel Mizrahi, Aharon Nachshon, et al.Nature Communications|October 6, 2021
Increased lethality in influenza and SARS-CoV-2 coinfection is prevented by influenza immunity but not SARS-CoV-2 immunityHagit Achdout, Einat B Vitner, Boaz Politi, et al.Pageof 8